- Dyne Therapeutics (NASDAQ:DYN) announces the pricing of an underwritten public offering of 17.15 million shares of its common stock at a public offering price of $17.50 per share, for an expected gross proceeds to be approximately $300.1 million.
- All shares in the offering are being sold by Dyne.
- The offering is expected to close on or about January 9, 2024.
- The company said it expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 2.57 million shares of its common stock at the public offering price.
